EyePoint Pharmaceuticals, Inc. Other Assets, Current in USD from Q4 2021 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of current assets classified as other.
Summary: EyePoint Pharmaceuticals, Inc. quarterly Other Assets, Current history and growth rate from Q4 2021 to Q3 2025.
EyePoint Pharmaceuticals, Inc. Other Assets, Current for the quarter ending September 30, 2025 was $899K, a 30.7% decline year-over-year.

Other Assets, Current, Quarterly (USD)

Other Assets, Current, YoY Quarterly Growth (%)

EyePoint Pharmaceuticals, Inc. Quarterly Other Assets, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$899K	-$399K	-30.7%	Sep 30, 2025	10-Q	2025-11-06
Q2 2025	$1.57M	+$507K	+47.6%	Jun 30, 2025	10-Q	2025-08-07
Q1 2025	$1.4M	-$82K	-5.53%	Mar 31, 2025	10-Q	2025-05-08
Q4 2024	$1.41M	+$396K	+39.2%	Dec 31, 2024	10-Q	2025-11-06
Q3 2024	$1.3M	+$749K	+136%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$1.07M	+$1.07M		Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$1.48M	+$1.48M		Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$1.01M	+$227K	+29%	Dec 31, 2023	10-K	2025-03-06
Q3 2023	$549K			Sep 30, 2023	10-Q	2023-11-03
Q2 2023	$0			Jun 30, 2023	10-Q	2023-08-04
Q1 2023	$0			Mar 31, 2023	10-Q	2023-05-04
Q4 2022	$782K	+$265K	+51.3%	Dec 31, 2022	10-K	2024-03-08
Q4 2021	$517K			Dec 31, 2021	10-K	2023-03-10

* An asterisk sign (*) next to the value indicates that the value is likely invalid.